03:21 AM EDT, 05/06/2024 (MT Newswires) -- Jeremy Bender, Director, Chief Executive Officer, on May 01, 2024, sold 79,211 shares in Day One Biopharmaceuticals ( DAWN ) for $1,415,707. Following the Form 4 filing with the SEC, Bender has control over a total of 1,686,326 shares of the company, with 642,602 shares held directly and 1,043,724 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1845337/000141588924012255/xslF345X03/form4-05032024_100509.xml

Price: 17.25, Change: +0.08, Percent Change: +0.47